Method of forming an aerosol for inhalation delivery

Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

Methods of Reducing Alcohol-Induced Dose Dumping for Opioid Sustained Release Oral Dosage Forms

Method to treat premature ejaculation in humans

Oral pharmaceutical dosage forms

6-Aminomorphinane Derivatives, Method for the Production and Use Thereof

Selective opioid compounds

Novel compositions and methods for enhancing potency or reducing adverse side effects of opiold agonists

Extended release formulations of guaifenesin

Controlled release hydrocodone formulations

Quaternary opioid carboxamides

PHARMACEUTICAL COMPOSITIONS

Treatment of sequelae of psychiatric disorders

Oxymorphone Controlled Release Formulations

Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders

Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs

Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents

Low Viscosity Liquid Polymeric Delivery System

Antitussive agent

Pharmaceutical compositions

Misuse preventative, controlled release formulation

Antipruritic agent for pruritus caused by multiple sclerosis

Micronized opioid compositions having a specific particle size distribution

TAMPER RESISTANT DOSAGE FORMS

Opioid and opioid-like compounds and uses thereof

Pharmaceutical compositions

Pharmaceutical composition

Sustained release formulations containing acetaminophen and tramadol

DRUGS AS WELL AS THEIR PRODUCTION AND USE IN THE TREATMENT OF PAIN-ASSOCIATED NEUROPATHIES

IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF DOPAMINE AGONIST

Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs

Alcohol Resistant Pharmaceutical Formulations

Particles in a capsule

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

Reduced dose intravenous acetaminophen

METHODS OF TREATING PAIN

5-substituted benzofurans as inhibitors of cytochrome P450 2D6

Parenteral formulations of dopamine agonists

Method of stimulating the motility of the gastrointestinal system using ipamorelin

Disintegratable films for diagnostic devices

SUSTAINED-RELEASE PREPARATIONS AND METHOD FOR PRODUCING THE SAME

Pharmaceutical Compositions

Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol

Controlled release tramadol formulations

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS

Combination analgesic employing opioid and neutral antagonist

Method for therapy of diarrhea-predominant irritable bowel disorders

METHOD FOR TREATING AND/OR PREVENTING DRUG SEEKING BEHAVIOR

PREVENTION AND TREATMENT OF FUNCTIONAL SOMATIC DISORDERS, INCLUDING STRESS-RELATED DISORDERS

Combination therapy

Long term drug delivery devices with polyurethane based polymers and their manufacture

MAGNETOPHORESIS APPARATUS AND METHOD OF USE

Methods and Compositions for the Treatment of Pruritus

Long acting dual release product containing carbinoxamine and pseudoephedrine

4-ACYLAMINOPYRIDINE DERIVATIVE MEDIATED NEUROGENESIS

METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

Tamper resistant dosage forms

Pharmaceutical composition containing gelling agent

METHODS AND COMPOSITIONS FOR TREATING PAIN

Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)

Therapeutic Agent for Constipation

ORALLY ADMINSTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

Compositions and methods for delivery of poorly soluble drugs

ADMINISTRATION OF AGONIST-ANTAGONIST IN OPIOID-DEPENDENT PATIENTS

Method for decreasing opioid metabolism

Compositions and methods for prophylaxis and treatment of addictions

Use of opioid receptor antagonists

PHARMACEUTICAL COMBINATION OF OPIOID AND PROSTAGLANDIN COMPOUND

Sustained release formulations of nalbuphine

SYNERGISTIC COMBINATION FOR THE TREATMENT OF PAIN (CANNABINOID RECEPTOR AGONIST AND OPIOID RECEPTOR AGONIST)

ADENOSINE A2A RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS

Therapeutic use of a derivative of thienylcyclohexylamine

ANALGESIA METHOD

Oral drug delivery system

Oral drug delivery system

FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS

Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same

Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof

Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion

Self-supporting films for pharmaceutical and food use

Sustained release micropellets and process for producing the same

Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion

Treatment of Depression

PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM

Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof

DUAL PORTION DOSAGE LOZENGE FORM

Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment

Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment

Methods of diagnosing endometriosis

PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM

Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds

Abuse resistant drug formulation

Tamper-resistant oral opioid agonist formulations

Tamper-resistant oral opioid agonist formulations

PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM

CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM

IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF DOPAMINE AGONIST

Abuse-proof dosage form

Tamper-resistant oral opioid agonist formulations

Transdermal delivery peptides and method of use thereof

Tamper-resistant oral opioid agonist formulations

Ibuprofen-Hydrocodone-Antihistamine Composition

Combination Therapy for Relief of Pain

TOPICAL THERAPIES FOR ORAL MUCOSITIS AND OTHER CONDITIONS

Disintegratable films for diagnostic devices

Opioid agonist/antagonist combinations

Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance

Pharmaceutical composition for the treatment of acute disorders

Morphinan compounds

High throughput screen utilizing newly discovered intramolecular neuronal calcium channel interactions to discover new analgesics

Anti-itching agent

TRANSDERMAL DELIVERY DEVICE DISPOSAL SYSTEM

Use of opioid antagonists to attenuate endothelial cell proliferation and migration

OXYMORPHONE CONTROLLED RELEASE FORMULATIONS

Reducing Side Effects of Tramadol

TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING

MULTIPLE ACTIVE DRUG RESIN CONJUGATE

SUSTAINED RELEASE COMPOSITIONS OF DRUGS

Multiparticulates

Morphine polymer release system

Polymer release system

Chitosan Containing Solution

ABUSE-PROOFED ORAL DOSAGE FORM

Pharmaceutical Compositions Useful in the Treatment of Pain

FORM OF ADMINISTRATION SECURED AGAINST MISUSE

INHIBITORS OF THE CERAMIDE METABOLIC PATHWAY AS ADJUNCTS TO OPIATES FOR PAIN

N-Oxides of 4,5-Epoxy-Morphinanium Analogs

Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist

Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist Microspheres

Pharmaceutical compositions

SUSTAINED RELEASE PARENTERAL FORMULATIONS OF BUPRENORPHINE

Polymorphic forms of naltrexone

Agent For Suppressing Development of Tolerance to Narcotic Analgesics

Sublingual Coated Tablet

Controlled Release Formulations

Morphine and Morphine Precursors

Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

EXTENDED RELEASE MATRIX FORMULATIONS OF MORPHINE

METHODS OF TREATING ANXIETY DISORDERS

Crystalline forms of an 8-azabicyclo(3.2.1)octane compound

PHARMACEUTICAL COMPOSITIONS OF HYDROMORPHONE FOR PREVENTION OF OVERDOSE OR ABUSE

Use of nalbuphine and related compounds to treat symptoms of respiratory problems

Oral drug delivery system

Use of Oxycodone for Treating Visceral Pain

ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS

Drug Detoxification Protocol Using Microdosing

Modulation of Cell Barrier Dysfunction

Morphine Sulfate Formulations

COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION AND ATTENDANT SIDE EFFECTS OF MU OPIOID COMPOUNDS

Methods and Therapies for Potentiating a Therapeutic Action of an Opioid Receptor Agonist and Inhibiting and/or Reversing Tolerance to Opioid Receptor Agonists

ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

Methods for treating acute and subchronic pain

Dosage forms for administering combinations of drugs

Delivery of drug esters through an inhalation route

Treatment of pain with naloxone

Abuse-resistant oral dosage forms and method of use thereof

Pharmaceutical Composition

Dosage Form Containing Oxycodone and Naloxone

TRANSDERMAL DELIVER OF ACTIVE AGENTS

Opioid dosage forms having dose proportional steady state Cand AUC and less than dose proportional single dose C

SYNERGISTIC COMBINATIONS OF NORKETAMINE AND OPIOID ANALGESICS

PHENYLEPHRINE TANNATE, PYRILAMINE TANNATE AND DEXTROMETHORPHAN TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS

NEW APORPHINE ESTERS AND THEIR USE IN THERAPY

IMMEDIATE RELEASE OXYMORPHONE COMPOSITIONS AND METHODS OF USING SAME

COMBINATION THERAPY FOR THE TREATMENT OF PAIN

Layered pharmaceutical formulations

COMPOSITIONS COMPRISING NANOPARTICULATE NAPROXEN AND CONTROLLED RELEASE HYDROCODONE

METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS

Method of restoring the incretin effect

COMBINATION THERAPY FOR THE TREATMENT OF PAIN

COMPOSITIONS COMPRISING NANOPARTICULATE MELOXICAM AND CONTROLLED RELEASE HYDROCODONE

Rapid release mini-tablets provide analgesia in laboratory animals

Composition for Treatment of Pain Specification

Neurotensin receptor agonists and opioid receptor agonists

Novel Pharmaceutical Composition And Their Uses Thereof For Controlling The Different Forms Of Addiction To Drugs

Use of Selective Opiate Receptor Modulators In the Treatment Of Neuropathy

Liquid depot formulations

Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs

Controlled release oxycodone compositions

Formulations for parenteral delivery of compounds and uses thereof

Novel Formulations For Opioid-Based Treatments Of Pain Comprising 1-(1,2-Disubstituted Piperidinyl)-4-Substituted Piperazine Derivatives

Abuse resistant drug formulation

Abuse-resistant controlled-release opioid dosage form

Dry powder compound formulations and uses thereof

Prolonged-release multimicroparticulate oral pharmaceutical form

Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

Pharmaceutical composition for treating fecal incontinence and anal itch

Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy

MILNACIPRAN FOR THE TREATMENT OF COGNITIVE DYSFUNCTION ASSOCIATED WITH FIBROMYALGIA

MILNACIPRAN FOR THE TREATMENT OF FATIGUE ASSOCIATED WITH FIBROMYALGIA SYNDROME

Sustained release formulations of oxymorphone

Analgesic combination of tramadol and meloxicam

ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

Methods and compositions for preventing or treating cardiovascular disease

Methods related to the treatment of neurodegenerative and inflammatory conditions

Recombinant A2-specific TNFα-specific antibodies

METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL

SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule Coats

Preoperative Treatment of Post Operative Pain

Implantable polymeric device for sustained release of buprenorphine

Controlled release formulations and associated methods

TRANSDERMAL DOSAGE FORM COMPRISING AN ACTIVE AGENT AND A SALT AND A FREE-BASE FORM OF AN ADVERSE AGENT

Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists

PHARMACEUTICAL SUSPENSIONS AND RELATED METHODS

Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction

Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction

TOPICAL COMPOSITIONS WITH LONG LASTING EFFECT

Narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction

Intranasal Opioid Compositions

Methods of treating rheumatoid arthritis with anti-TNF antibodies

Analgesic and methods of treating pain

Therapeutic Agent for Neuropathic Pain

Method for treating pain with a calmodulin inhibitor

Particulates

Transdermal Therapeutic System For Administering Analgesics

DRUG ADMINISTRATION METHODS

Methods of treating joint pain in a subject by using an anti-angiogenic agent

Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate

Rectal Composition

Sustained release formulation of naltrexone

Sustained release formulations of opioid and nonopioid analgesics

Sustained release oxycodone composition with acrylic polymer and surfactant

Adhesive solid gel-forming formulations for dermal drug delivery

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

Controlled release oxycodone compositions

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

5 HT receptor mediated neurogenesis

METHOD FOR REDUCING PAIN

Pharmaceutical formulation comprising ziconotide

Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same

Pharmaceutical compositions and methods for peptide treatment

Opioid depot formulations

Methods and compositions for deterring abuse of opioid containing dosage forms

USING NALTREXONE AS A MULTI-PURPOSE HEALTH SUPPLEMENT TO IMPROVE THE HUMAN CONDITION AND PREVENTING MULTIPLE DISEASES AND INFIRMITIES BY STIMULATING IMMUNE SYSTEM VITALITY AND ROBUSTNESS

Alcohol Resistant Dosage Forms

Controlled release formulations exhibiting an ascending rate of release

Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain

Drug delivery to ilioinguinal nerve to alleviate chronic pelvic pain

Compositions and methods useful for treatment of respiratory illness

ANTIBIOTIC/BONE MORPHOGENIC PROTEIN FORMULATION AND METHOD OF TREATMENT

ANTIBIOTIC FORMULATION AND METHOD OF TREATMENT

Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain

Drug delivery to alleviate chronic pelvic pain

Pharmaceutical removal of neuronal extensions from a degenerating disc

Compositions and kits useful for treatment of respiratory illness

Compositions and methods useful for treatment of respiratory illness

Multi-compartment transdermal pain control device

MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS

Combination of Dermaciclane and Opoids as Analgesics

Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline

Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive

METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL

METHOD OF TREATING PAIN BY ADMINISTERING 24 HOUR ORAL OPIOID FORMULATIONS EXHIBITING RAPID RATE OF INITIAL RISE OF PLASMA DRUG LEVEL

Opiopathies

Analgesics

Anti-misuse microparticulate oral pharmaceutical form

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Modified release formulations containing drug-ion exchange resin complexes

Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same

Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same

Cancer Treatment Method

Dosage forms for administering combinations of drugs

Tamper resistant dosage form comprising an adsorbent and an adverse agent

Dextromethorphan-based method for treating acne

Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals

Compositions and methods in the treatment of bone metabolic disorders

PHENYLEPHRINE TANNATE AND PYRILAMINE TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS

Analgesic combination of oxycodone and celecoxib

Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor

3,4,6-Substituted pyridazines for treating neuropathic pain and associated syndromes

Dosage forms for the delivery of drugs of abuse and related methods

Opioids for the treatment of the restless leg syndrome

Opioids for the treatment of the chronic obstructive pulmonary disease (COPD)

Noribogaine in the treatment of pain and drug addiction

DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE

Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone

METHODS OF TREATING ANXIETY DISORDERS

FLAVOR-ENHANCING COMPOSITIONS, METHOD OF MANUFACTURE, AND METHODS OF USE

Delivery of opioids through an inhalation route

Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin

Methods and compositions for deterring abuse of opioid containing dosage forms

Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain

Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction

Prolonged release bioadhesive therapeutic systems

Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same

SUSTAINED-RELEASE FORMULATION OF ZONISAMIDE

Abuse resistant transmucosal drug delivery device

Pharmaceutical composition

SEQUENTIAL RELEASE PHARMACEUTICAL FORMULATIONS

Methods of treating psoriasis with anti-TNF antibodies

Opioid formulations having reduced potential for abuse

Oxymorphone controlled release formulations

Pharmaceutical compositions with increased activity

Compositions and methods for reducing food cravings

Compositions and methods for increasing insulin sensitivity

Product designed to protentiate the therapeutic effects and to enhance the action of medicinal preparations